Related Experiment Video
Updated: Jun 13, 2026
06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
The genetics of multiple sclerosis: an update 2010
Sabine Hoffjan1, Denis A Akkad
1Department of Human Genetics, Ruhr-University, Universitätsstrasse 150, 44801 Bochum, Germany. sabine.hoffjan@ruhr-uni-bochum.de
Molecular and Cellular Probes
|May 11, 2010
Summary
Genome-wide association studies (GWAS) reveal new multiple sclerosis (MS) susceptibility genes, including IL7RA and CLEC16A. These findings highlight shared genetic factors across autoimmune diseases and potential pharmacogenomic insights for MS treatment.
Area of Science:
- Neuroimmunology
- Genetics
- Pharmacogenomics
Background:
- Multiple sclerosis (MS) is a chronic neuro-inflammatory autoimmune disease.
- Complex interactions of environmental and genetic factors are implicated in MS etiology.
- Genome-wide association studies (GWAS) have advanced understanding of MS genetic underpinnings.
Purpose of the Study:
- To identify novel genetic susceptibility factors for multiple sclerosis.
- To explore shared genetic backgrounds among autoimmune disorders.
- To investigate genetic influences on interferon beta (IFNb) treatment response in MS.
Main Methods:
- Analysis of >100,000 single nucleotide polymorphism markers using chip technology in GWAS.
- Replication of identified susceptibility genes across multiple populations.
- Examination of gene variations associated with IFNb treatment response in MS patients.
Main Results:
- Identification and replication of key MS susceptibility genes such as IL7RA, IL2RA, CD58, and CLEC16A.
- Evidence of overlapping genetic susceptibility variants between MS and other autoimmune diseases.
- Association of genes coding for neurotransmitter-gated channels, like GPC5, with IFNb response in MS.
Conclusions:
- GWAS have significantly contributed to understanding the genetic architecture of MS.
- Shared genetic factors likely contribute to the pathogenesis of multiple autoimmune conditions.
- Pharmacogenomic studies, particularly focusing on GPC5, offer potential for personalized MS treatment strategies.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:43Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...